Who We Are

Meet Our Leadership Team

Doug Donzelli

CEO

Doug is a serial entrepreneur and CEO with over 40 years of experience in technology. Doug’s domain and technology experience includes healthcare, medical devices, industrial process chemistry, and software development.

Peter Madrid, PhD

Scientific Development

Peter brings over 17 years of leadership experience in transformative chemistry and automation technologies and joined the Synfini team after his tenure at SRI Biosciences. Peter’s career has been focused on developing new therapeutics and diagnostics for infectious diseases with unmet medical needs.

Nathan Collins, PhD

Strategic Alliance

Nathan is an experienced biotech executive with 25 plus years in the drug discovery industry. He was the Chief Strategy Officer at SRI Biosciences and is the Synfini visionary. Nathan has a strong background in managing drug, diagnostic and technology pipelines from target identification through clinical development.

John Byrnes, PhD ​

Artificial Intelligence

John brings over 25 years of AI research experience to Synfini after directing the Advanced Inference and Learning Group in SRI’s Artificial Intelligence Center. John’s research in machine reasoning and machine learning has been applied to language understanding, healthcare, and molecular design.

Elizabeth Miyagi ​

Finance

Liz leads finance for Synfini. She is an experienced finance executive with over 30 years of startup financial management and fundraising support.